Hou, Xiaoqiong
94  Ergebnisse:
Personensuche X
?
 
?
4

Endoglin-Aptamer-Functionalized Liposome-Equipped PD-1-Sile..:

Xie, Shenxia ; Hou, Xiaoqiong ; Yang, Wei...
International Journal of Nanomedicine.  16 (2021)  - p. 6017-6034 , 2021
 
?
5

Nanobody-based chimeric antigen receptor T cells designed b..:

Mo, Fengzhen ; Duan, Siliang ; Jiang, Xiaobing...
Signal Transduction and Targeted Therapy.  6 (2021)  1 - p. , 2021
 
?
6

Single-Domain Antibody-Based TCR-Like CAR-T: A Potential Ca..:

Zhu, Lichen ; Yang, Xiaomei ; Zhong, Dani...
Journal of Immunology Research.  2020 (2020)  - p. 1-8 , 2020
 
?
7

In vivo Targeting of Liver Cancer with Tissue- and Nuclei-S..:

Ding, Ziqiang ; Wang, Dujin ; Shi, Wei...
International Journal of Nanomedicine.  15 (2020)  - p. 8383-8400 , 2020
 
?
12

A Novel Strategy for Simulating the Main Fractionator of De..:

LEI, Yang ; ZHANG, Bingjian ; HOU, Xiaoqiong.
Chinese Journal of Chemical Engineering.  21 (2013)  3 - p. 285-294 , 2013
 
?
13

Design and simulation of an entrainer-enhanced ethyl acetat..:

Hu, Song ; Zhang, Bing-jian ; Hou, Xiao-qiong..
Chemical Engineering and Processing: Process Intensification.  50 (2011)  11-12 - p. 1252-1265 , 2011
 
?
14

Nanobody-based trispecific T cell engager (Nb-TriTE) enhanc..:

Ding, Ziqiang ; Sun, Shuyang ; Wang, Xuan...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10688028/.  , 2023
 
1-15